Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series - 06/11/18
Doi : 10.1016/j.jaci.2018.06.030
Mirjam E. Belderbos, MD, PhD a 
, Andrew R. Gennery, MBChB, MD b, Christopher C. Dvorak, MD c, Henric-Jan Blok, MSc d, Dirk-Jan Eikema, PhD d, Juliana M.F. Silva, MD e, Paul Veys, MD, PhD e, Bénédicte Neven, MD, PhD f, Rebecca Buckley, MD g, Theresa Cole, MD h, Morton J. Cowan, MD c, W. Scott Goebel, MD, PhD i, Manfred Hoenig, MD, PhD j, Caroline Y. Kuo, MD k, E. Richard Stiehm, MD k, Robert Wynn, MD l, Marc Bierings, MD, PhD a, m
on behalf of the
, Andrew R. Gennery, MBChB, MD b, Christopher C. Dvorak, MD c, Henric-Jan Blok, MSc d, Dirk-Jan Eikema, PhD d, Juliana M.F. Silva, MD e, Paul Veys, MD, PhD e, Bénédicte Neven, MD, PhD f, Rebecca Buckley, MD g, Theresa Cole, MD h, Morton J. Cowan, MD c, W. Scott Goebel, MD, PhD i, Manfred Hoenig, MD, PhD j, Caroline Y. Kuo, MD k, E. Richard Stiehm, MD k, Robert Wynn, MD l, Marc Bierings, MD, PhD a, m on behalf of the
Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium
a Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands
b Department of Pediatric Immunology, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
c Pediatric Allergy Immunology and Blood and Marrow Transplant Division, University of California–San Francisco, Benioff Children's Hospital, San Francisco, Calif
d Department of Medical Statistics and Bioinformatics, Leiden University Medical Center, Leiden, The Netherlands
e Department of Bone Marrow Transplantation, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
f Department of Pediatric Hematology-Immunology, Hospital Necker-Enfants Malades, Assistance Publique-Hôspitaux de Paris, INSERM, Paris, France
g Departments of Pediatrics and Immunology, Duke University School of Medicine, Duke University Medical Center, Durham, NC
h Department of Allergy and Immunology, Royal Children's Hospital, Melbourne, Australia
i Department of Pediatrics and the Pediatric Stem Cell Transplantation Program, Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Ind
j Department of Pediatrics, University Medical Center Ulm, Ulm, Germany
k Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, David Geffen School of Medicine, UCLA Medical Center, Los Angeles, Calif
l Department of Pediatric Blood and Marrow Transplant, Royal Manchester Children's Hospital, Manchester, United Kingdom
m Department of Pediatric Hematology and Stem Cell Transplantation, Wilhelmina Children's Hospital, Utrecht, The Netherlands
| The Primary Immune Deficiency Treatment Consortium is supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (Principal Investigator: M.J.C.). The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US Government. M.E.B. is financially supported by a Bas Mulder Award from the Dutch Cancer Society (grant no. RUG 2015-7964). |
|
| Disclosure of potential conflict of interest: M. E. Belderbos is financially supported by a Bas Mulder Award from the Dutch Cancer Society (grant no. RUG 2015-7964). The rest of the authors declare that they have no relevant conflicts of interest. |
© 2018
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 142 - N° 5
P. 1628 - novembre 2018 Retour au numéro
Article précédent
- Thirdhand smoke component can exacerbate a mouse asthma model through mast cells
- Mang Yu, Kaori Mukai, Mindy Tsai, Stephen J. Galli
- An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation
- Teresa Song, Ana B. Pavel, Huei-Chi Wen, Kunal Malik, Yeriel Estrada, Juana Gonzalez, Peter W. Hashim, John K. Nia, Danielle Baum, Grace Kimmel, Giselle K. Singer, James G. Krueger, Emma Guttman-Yassky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?